Jekaterina Prikulis

Jekaterina Prikulis

Auto-generated profile, based on publicly available information

Jekaterina Prikulis

Saint Petersburg State University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2026 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
JPJekaterina Prikulis
Jekaterina Prikulis
ПЕПрикулис Екатерина
Прикулис Екатерина
AKAlla S. Kalugina
Alla S. Kalugina
КСКалугина Алла Станиславовна
Калугина Алла Станиславовна
YTYulia A. Tatishcheva
Yulia A. Tatishcheva
ГМГзгзян Александр Мкртичевич
Гзгзян Александр Мкртичевич
BACKGROUND: Despite the widespread use of assisted reproductive technology (ART) treatments, the impact of the male factor on embryo quality remains insufficiently understood. Data regarding the effect of preconception stimulation of spermatogenesis on embryological outcomes in patients with pathospermia are limited and contradictory, which underscores the relevance of the present study. AIM: The aim of this study was to evaluate the effect of preconception care in men with pathospermia on spermatogenesis parameters and embryological outcomes in ART programs. METHODS: This prospective comparative study included 92 men with pathospermia undergoing ART treatment. The intervention group (n = 44) received a course of spermatogenesis stimulation therapy, whereas the control group (n = 48) underwent ART without prior preparation. The study groups were comparable in terms of male and female age, number of mature oocytes, and baseline semen characteristics. We assessed changes in spermatogenesis parameters and embryological outcomes, including the normal fertilization rate, number of day-5 embryos, total number of embryos obtained, and number of high-quality embryos. RESULTS: In the intervention group, sperm concentration, progressive motility, and normal morphology improved significantly following the stimulation therapy. However, we observed no effect of spermatogenesis stimulation on the fertilization rate (odds ratio 1.197; 95% confidence interval 0.860–1.665). In addition, the intervention group demonstrated higher numbers of day-5 embryos (p = 0.031), total embryos obtained (p = 0.041), and high-quality embryos (p = 0.045). The odds of obtaining a high-quality embryo were nearly twofold higher in patients who underwent spermatogenesis stimulation (odds ratio 1.88; 95% confidence interval 1.053–3.357). CONCLUSION: Male preconception care improves semen parameters and enhances embryo quality but does not affect fertilization rates in ART cycles. The observed effect is likely associated with improved sperm DNA integrity, which is not reflected by conventional semen analysis parameters. These findings support the use of spermatogenesis stimulation to optimize embryological outcomes and improve ART effectiveness. Further research is required to evaluate the impact of this approach on clinical ART outcomes, including pregnancy and live birth rates.

7 December 2024 in Marine Medicine
Verified
Journal Article
Open access
PDF file
JPJekaterina Prikulis
Jekaterina Prikulis
LSLyudmila G. Stepanyan
Lyudmila G. Stepanyan
YSYanina M. Sagurova
Yanina M. Sagurova
EKEvgeniya M. Komarova
Evgeniya M. Komarova
ELElena A. Lesik
Elena A. Lesik
IKIgor Yu. Kogan
Igor Yu. Kogan
INTRODUCTION . Spermogram parameters such as sperm concentration, motility and morphology are used to evaluate the intensity of spermatogenesis, as well as some stages of the embryological stage of assisted reproductive technology (ART) programs: fertilization and embryo fragmentation. However, the prognostic value of the standard spermiologic study for ART outcomes remains controversial. OBJECTIVE . To evaluate the effect of sperm concentration, motility and morphology on the onset of clinical pregnancy, incidence of unintended pregnancy and live birth in patients who have undergone ART procedures. MATERIALS AND METHODS. A single-center retrospective study involved 557 couples treated by in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Depending on the results of spermograms, 4 groups were formed: patients with normozoospermia ( n = 139), asthenozoospermia ( n = 126), teratozoospermia ( n = 149) and oligo-, oligoasthenoteratozoospermia ( n = 143). Descriptive statistics, chi-square test and logistic regression were used to assess outcomes. RESULTS . Clinical pregnancy rate in in the group with normozoospermia was 37,4 %, which is significantly higher than in the group with asthenozoospermia (23,0 %), teratozoospermia (24,2 %) and comorbidity (21,7 %) ( p = 0,010). Live birth rate was highest in the group with normozoospermia – 32,4 %, compared to 15,9 % with asthenozoospermia and 16,8 % with comorbidity ( p = 0,003). Logistic regression analysis has showed that increasing sperm motility raises probability of live birth 1,010 times ( p = 0,033). However, the model has explained only 1,3% of variance in outcomes, indicating its low predictive power. DISCUSSION . The study results show that pathozoospermia is associated with reduced likelihood of pregnancy and live birth in ART programs, which is consistent with other studies. However, the association of spermogram parameters with the effectiveness of ART is not confirmed in all studies, indicating that additional factors, such as sperm DNA fragmentation, need to be taken into account. In addition, differences in outcomes may be related to equipment and approaches to ART procedures. CONCLUSION . Simple spermogram parameters, such as sperm concentration, motility and morphology, can predict the outcome of ART, including the rate of clinical pregnancy and live birth, However, their prognostic value remains limited, requiring further research to develop more accurate prediction models.

30 April 2026 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
JPJekaterina Prikulis
Jekaterina Prikulis
LDLyailya Kh. Dzhemlikhanova
Lyailya Kh. Dzhemlikhanova
DNDariko A. Niauri
Dariko A. Niauri
AGAlexander M. Gzgzyan
Alexander M. Gzgzyan
ПЕПрикулис Екатерина
Прикулис Екатерина
ГМГзгзян Александр Мкртичевич
Гзгзян Александр Мкртичевич
Disorders of spermatogenesis represent a significant yet insufficiently studied factor that influences the outcomes of assisted reproductive technology (ART) programs and the incidence of early reproductive loss. The aim of this review was to systematize current evidence on the relationship between routine and advanced parameters used for the assessment of spermatogenesis and embryo quality, ART effectiveness, and the risk of implantation failure. The results of large retrospective and prospective studies, as well as systematic reviews and meta-analyses, addressing the role of sperm concentration, motility, morphology, and sperm DNA fragmentation in determining embryological and clinical outcomes of ART have been analyzed. It has been shown that conventional semen parameters have limited prognostic value, whereas sperm DNA fragmentation is associated with reduced clinical pregnancy rates and an increased risk of miscarriage. Special attention is given to modern methods for assessing sperm DNA integrity and their diagnostic capabilities. The review also discusses the impact of oxidative stress and the role of antioxidant therapy in the context of male preconception preparation prior to ART programs. The review highlights the importance of a comprehensive evaluation of male reproductive function and a personalized approach to patient management in order to improve ART outcomes and reduce the risk of early reproductive loss.

3 July 2026 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
JPJ. Prikulis
J. Prikulis
OZO.B. Zhukov
O.B. Zhukov
VKV.V. Kotov
V.V. Kotov
SBSergey Vladimirovich Bogolyubov
Sergey Vladimirovich Bogolyubov
DND.A. Niauri
D.A. Niauri
AGA.M. Gzgzyan
A.M. Gzgzyan
Male factor infertility remains one of the leading causes of reduced reproductive potential in couples, accounting for up to 50% of infertility cases. Traditional semen analysis parameters do not always reflect the true fertility status, as a significant proportion of men with normal ejaculate parameters are diagnosed with impaired sperm genetic integrity. One of the key mechanisms of sperm damage is oxidative stress. Consequently, pathogenetically substantiated complex antioxidant and metabolic support for spermatogenesis is of particular interest. Objective. To evaluate changes in spermatogenesis parameters and sperm DNA fragmentation levels in men with idiopathic pathospermia following administration of a combined antioxidant complex. Material and methods. A multicenter observational study included 118 men aged 25—55 years with idiopathic pathospermia. Participants received a combined antioxidant complex for 90 days. The following parameters were assessed: ejaculate volume, sperm concentration, progressive motility, sperm morphology and the level of DNA fragmentation measured by the TUNEL assay. Semen analysis was performed before the initiation of therapy and after three months of therapy. Results. Administration of the studied complex was associated with statistically significant improvement in the main parameters (volume, concentration, progressive motility and sperm morphology) and a reduction in DNA fragmentation levels (p<0.001). Positive dynamics of the corresponding parameters were noted in subgroups of patients with baseline oligozoospermia, asthenozoospermia and teratozoospermia (p<0.05). Conclusions. The use of combined antioxidant complex was associated with a statistically significant improvement in spermatogenesis parameters and a decrease in sperm DNA fragmentation levels in men with idiopathic pathospermia. The obtained findings suggest that pathogenetically oriented nutritional antioxidant support may represent a potentially promising approach for the management of spermatogenesis disorders. However, the observational design of the study and the absence of a control group limit the possibility of causal interpretation of the observed changes. Further randomized controlled studies are required to further evaluate these findings and their potential clinical significance.